in Women With Postmenopausal Osteoporosis – A Randomized Controlled Trial Context Risedronate, a potent bisphosphonate, has been shown to be effective in the treatment of Paget disease of bone and other metabolic bone diseases but, to our knowledge, it has not been evaluated in the treatment of established postmenopausal osteoporosis. Objective To test the efficacy […]